Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane((R))) on three treatment schedules in patients with solid tumors Article Proceedings Paper

cited authors

  • Stinchcombe, Thomas E.; Socinski, Mark A.; Walko, Christine M.; O'Neil, Bert H.; Collichio, Frances A.; Ivanova, Anastasia; Mu, Hua; Hawkins, Michael J.; Goldberg, Richard M.; Lindley, Celeste; Dees, E. Claire

Publication Date

  • October 1, 2007

webpage

published in

category

keywords

  • clinical trial
  • dose-limiting toxicity
  • maximum tolerated dose
  • melanoma
  • non-small-cell lung cancer
  • small-cell lung cancer

start page

  • 759

end page

  • 766

volume

  • 60

issue

  • 5